The USDA’s Dairy Market News report for the week of June 22 through 26 describes a whey protein concentrate market stretched to its limit, with “product largely unavailable” and buyers continuing to report difficulty securing supply. The same report puts whey protein isolate at $13.50 to $14 per pound and WPC 80% in the $12.50 to $13 range. A late-April USDA report found some suppliers already sold out for the remainder of the year, and end-of-month whey protein inventories have fallen by roughly half since 2023, according to USDA data cited by CNBC.
The price trajectory behind those figures is steep. Leonard Polzin, an agricultural economist at the University of Wisconsin-Madison, told ABC News in early June that WPC 34%, a mid-protein grade, has risen about 20% over the past six months and nearly 83% over two years. Kathleen Wolfley of Ever.Ag Insights told the same outlet that high-protein whey stocks fell 7% year over year in March even as first-quarter production rose 6% from 2025. Production is growing. Demand is growing faster.
The constraint sits in an awkward place. Whey is a byproduct of cheesemaking, so the industry cannot build whey capacity in isolation; it comes attached to cheese plants, most of which were designed around steady, predictable growth rather than a demand spike. The specialized filtration infrastructure that converts liquid whey into high-protein powder can take years to win approval. Phil Plourd, a dairy analyst at Ever.Ag, told CNBC the U.S. has had solid milk growth for more than a year and a half, and that farm supply is not the problem.
The financing structure slows things further. David Steven Jacoby of Boston Strategies told CNBC that processors generally want signed contracts in hand before borrowing to build capacity, which is hard to arrange in the middle of a demand surge, and he estimated a single plant revamp runs around $15 million while large-scale industrial expansion would require hundreds of millions. Capital is moving anyway: U.S. dairy producers announced $11 billion in new manufacturing capacity across 19 states last October, according to the International Dairy Foods Association. But announced capacity is not installed capacity, and the gap between the two is measured in years.
The demand side keeps adding new floors. The International Food Information Council has found that around 70% of Americans say they are trying to consume more protein, up from 59% four years ago. Protein claims now appear in nearly every grocery category, from chips and waffles to ice cream and ready-to-drink coffee.
GLP-1 medications compound the effect. Medical guidance advises patients on these drugs to raise protein intake to preserve lean muscle during weight loss, and Numerator data cited by Grocery Dive found GLP-1 households outspend non-users by 25% on protein shakes. That population is about to grow: the Medicare GLP-1 Bridge program launched July 1, giving eligible beneficiaries access to weight-loss GLP-1s for a $50 monthly copay through the end of 2027, per CMS. Several million beneficiaries are expected to use the program, according to a Medicare official cited by CNBC.
The cost pressure has moved from commodity reports to income statements. BellRing Brands, the parent of Premier Protein and Dymatize, narrowed its fiscal 2026 outlook in February, with CEO Darcy Davenport citing “increased category promotional frequency and higher whey protein costs” in the company’s earnings release. By the company’s May report, adjusted gross margin for the first six months of fiscal 2026 had fallen to 26.1% of net sales from 35.8% a year earlier, a decline BellRing attributed to significant input cost inflation, including tariffs, and unfavorable price/mix.
The price/mix detail deserves a second look. Premier Protein’s second-quarter volume rose 6% while price/mix fell 5.7%, per the company’s SEC filing. The largest brand in the category is discounting into steep input inflation, not pricing over it, because promotional competition in the category is intense enough to demand it. The whey crunch is squeezing margins from below while the promotional environment blocks relief from above.
None of this upstream stress is visible on the shelf. Walmart has continued expanding protein-forward assortment across categories, and its merchandising posture treats the trend as durable. Walmart moved Aloha’s protein bars out of sports nutrition and into the center-store snack aisle, a placement decision FoodNavigator-USA reported in June alongside Aloha’s estimate that about 70% of protein bar category share now sits in center store. Aloha chief sales officer Shawn McLaughlin told the outlet that Walmart’s buyer framed the shift bluntly, describing better-for-you as “not a trend, it’s a lifestyle.”
Walmart’s own July 1 announcement makes the posture explicit. The company said customers will find more than 150 wellness-focused rollbacks this summer across categories including protein bars and powders, and it is introducing Wellness Minis, trial-size offerings from trending wellness brands, in 2,000 stores. Walmart is rolling back prices on protein products in the same week a core ingredient for many of them traded as high as $14 a pound, and that demand signal from Bentonville means the squeeze happens in the middle, on the companies that buy whey and sell finished goods.
For 1P suppliers with protein-fortified items, the exposure runs through two channels. The first is margin: a key input whose mid-protein grade is up more than 80% in two years eventually forces a cost conversation with a merchant team at a retailer built on price leadership, and BellRing’s numbers show why that conversation will be hard. When the category leader is deepening promotions rather than raising prices, a merchant has little reason to accept a cost increase on category-level narrative alone, and suppliers should expect to bring documented ingredient-cost evidence specific to their items. The second channel is continuity: with spot supply scarce, suppliers should be stress-testing whey supply agreements now against their fill-rate and OTIF commitments, because an ingredient shortfall becomes a Walmart scorecard problem long before it becomes a P&L problem. Reformulation is a live lever, and the market is already moving that way; Plourd pointed CNBC to Doritos Protein, which uses casein rather than whey. But reformulation changes the claim set on the package, and suppliers should weigh label and taste risk before swapping proteins on an item shoppers already know.
For 3P Marketplace sellers, the exposure is more direct and the response options are wider. Sellers of supplements, protein snacks, and ready-to-drink products absorb rising cost of goods immediately, and whey protein isolate, the grade at the top of the price range, is common in supplement formulations. Marketplace sellers control their own pricing and can reprice quickly, but repricing ahead of competitors carries Buy Box consequences, and sellers should model how long they can hold price against their remaining inventory cost basis before conceding the increase.
The June 25 USDA report contains the first hints of a turn: some buyers showing hesitancy at current prices, and some suppliers offering product for the first time in months. Plourd expects the spike to moderate rather than crash, telling CNBC that “high prices cure high prices,” while cautioning that the adjustment may take a few years. For suppliers planning protein launches into 2027 line reviews, that timeline is the number that matters: the constraint on the protein trend has moved upstream, from shelf space to supply, and it will still be there when the next planning cycle starts.